sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 1424.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 5-Jan-2018
Science Advances
Researchers unlocking potential for next-generation medical scanning
While still in the early stages, research reported today in the journal Science Advances has made significant steps towards a new MRI method with the potential to enable doctors to personalise life-saving medical treatments and allow real-time imaging to take place in locations such as operating theatres and GP practices.

Contact: Alistair Keely
alistair.keely@york.ac.uk
01-904-323-918
University of York

Public Release: 5-Jan-2018
Science Immunology
Immune response to Zika virus contributes to fetal harm
The same proteins that mount a potent immune response to Zika viral infection can also harm the placenta and fetal development, according to a Yale-led study published in Science Immunology.
National Institutes of Health

Contact: Ziba Kashef
ziba.kashef@yale.edu
203-436-9317
Yale University

Public Release: 5-Jan-2018
Science Immunology
How Zika infection drives fetal demise
An interferon cell receptor spurs cell suicide in fetuses infected with the Zika virus and could play a role in certain pregnancy complications.

Contact: Meghan Rosen
rosenm2@hhmi.org
301-215-8859
Howard Hughes Medical Institute

Public Release: 4-Jan-2018
The Lancet
Experts call for World Health Organization to rethink 'unacceptable' plans
The World Health Organization (WHO) has been accused of 'washing its hands of older people' in its proposed priorities for future work. In a letter published online in The Lancet, experts on ageing from the University of East Anglia (UEA) and the London School of Hygiene & Tropical Medicine (LSHTM) say the draft WHO 13th General Programme of Work makes no reference to older people or to conditions associated with later life, such as dementia.

Contact: Cat Bartman
communications@uea.ac.uk
44-016-035-93496
University of East Anglia

Public Release: 4-Jan-2018
Endocrine Reviews
Common birth control shot linked to risk of HIV infection
Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the Endocrine Society's journal Endocrine Reviews.
National Institutes of Health, Canadian Institutes of Health Research

Contact: Jenni Glenn Gingery
jgingery@endocrine.org
202-971-3655
The Endocrine Society

Public Release: 4-Jan-2018
PLOS Pathogens
Tick exosomes may aid transmission of viruses to vertebrates
Scientists have shown for the first time that exosomes from tick cells can aid transmission of viral proteins and genetic material from arthropod to vertebrate host cells, according to new research published in PLOS Pathogens.

Contact: PLOS Pathogens
plospathogens@plos.org
PLOS

Public Release: 4-Jan-2018
PLOS Neglected Tropical Diseases
Building stronger health systems could help prevent the next epidemic in Madagascar
The peak epidemic season for plague in Madagascar is fast approaching and the severity of these outbreaks could be significantly reduced with improvements to their public health system, argues Matthew Bonds from Harvard Medical School and the nongovernmental health care organization, PIVOT, in a new Viewpoint publishing Jan. 4, 2018, in PLOS Neglected Tropical Diseases.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 4-Jan-2018
Science
Hijacker parasite blocked from infiltrating blood
A major international collaboration led by Melbourne researchers has discovered that the world's most widespread malaria parasite infects humans by hijacking a protein the body cannot live without. The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
Australian National Health and Medical Research Council, Australian Research Council, National Institutes of Health, Howard Hughes Medical Institute, Wellcome Trust, Canadian Institutes of Health, Singapore National Medical Research Council, and others

Contact: Vanessa Solomon
solomon@wehi.edu.au
047-575-1811
Walter and Eliza Hall Institute

Public Release: 3-Jan-2018
First typhoid conjugate vaccine achieves WHO prequalification, a key step in protecting children and reducing the burden of typhoid
A typhoid conjugate vaccine has been prequalified by the World Health Organization (WHO), bringing the vaccine one step closer to reaching millions more people at risk of typhoid.
Typhoid Vaccine Acceleration Consortium

Contact: Hannah Bassett
hannah.bassett@sabin.org
202-621-1691
Sabin Vaccine Institute

Public Release: 2-Jan-2018
Plastic and Reconstructive Surgery
Educational video may increase public willingness to become face transplant donors
After watching a brief educational video, members of the public are more likely to say they would be willing to donate a facial transplant to a severely disfigured patient, reports a study in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 28-Dec-2017
PLOS Pathogens
Gene therapy using CAR T-cells could provide long-term protection against HIV
Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells not only destroyed the infected cells, they persisted for more than two years, suggesting the potential to create long-term immunity from the virus that causes AIDS.
Foundation for AIDS Research, California Institute for Regenerative Medicine, National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases

Contact: Tami Dennis
tdennis@mednet.ucla.edu
310-267-7007
University of California - Los Angeles Health Sciences

Public Release: 28-Dec-2017
PLOS Neglected Tropical Diseases
Cholera hotspots found at Uganda's borders and lakes
Uganda is among the countries is sub-Saharan Africa where cholera remains a recurring problem, despite advances in science and technology for prevention, detection and treatment of the infectious disease. Now, researchers reporting in PLOS Neglected Tropical Diseases have identified cholera hotspots around Uganda to help target interventions.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 27-Dec-2017
PLOS Medicine
Prevention, diagnosis, and treatment of STIs: A PLOS medicine collection
This week PLOS Medicine launches the research content in our Collection on Prevention, Diagnosis, and Treatment of Sexually Transmitted Infections (STIs), advised by Guest Editors Nicola Low of the University of Bern, Switzerland and Nathalie Broutet of the World Health Organization (WHO).

Contact: Nicola Low
nicola.low@ispm.unibe.ch
PLOS

Public Release: 22-Dec-2017
Journal of Infectious Diseases
Zika remains a research and public health challenge, say NIAID scientists
The Zika virus has become established in more than 80 countries, infected millions of people, and left many babies with birth defects. Although scientists have made progress in their understanding of the virus, it would be premature to think that the Zika pandemic is now under control and will not reemerge, perhaps more aggressively, say leaders from the National Institute of Allergy and Infectious Diseases in a Journal of Infectious Diseases special supplement.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Elizabeth Deatrick
elizabeth.deatrick@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-Dec-2017
Journal of Clinical Investigation Insight
Duke-led team develops more accurate tool to track new HIV infections
Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.
Bill & Melinda Gates Foundation, NIH/National Institute of Allergy and Infectious Diseases, US Military HIV Research Program, Henry M. Jackson Foundation

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 20-Dec-2017
Science Translational Medicine
Proof-of-concept study reveals feasibility of eliminating rabies in Africa
The Swiss Tropical and Public Health Institute, together with European and African collaborators, carried out a mass dog vaccination in Chad and determined its effect on human rabies exposure. The study published in Science Translational Medicine employed a bio-mathematical method for estimating the transmission dynamics of rabies. The researchers conclude that with political will and the necessary funding, elimination of rabies is possible in Africa.

Contact: Anna Wegelin
anna.wegelin@swisstph.ch
41-765-883-006
SWISS TPH, UNIVERSITY OF BASEL

Public Release: 19-Dec-2017
PLOS Biology
Storming the castle: New discovery in the fight against bacteria
Exciting new research reveals a previously unappreciated aspect of bacterial exterior membranes, which could be exploited to render antibiotic-resistant bacteria beatable. The research, publishing Dec. 19, in the open access journal PLOS Biology by Jean-François Collet at UCLouvain's de Duve Institute in Belgium and colleagues from the University of Utah and Imperial College London, potentially opens the door to promising new treatments.

Contact: Jean-François Collet
jfcollet@uclouvain.be
PLOS

Public Release: 18-Dec-2017
Structure
Dengue 'Achilles heel' insight offers hope for better vaccines
Researchers have new insights into how protective antibodies attack dengue viruses, which could lead to more effective dengue fever vaccines and drug therapies. The University of Queensland and China's ZhuJiang Hospital collaboratively led the study which identified an antibody that binds to, and kills, all four types of dengue virus.

Contact: Professor Paul Young
p.young@uq.edu.au
61-733-654-622
University of Queensland

Public Release: 18-Dec-2017
18 health innovations funded by Grand Challenges Canada to empower vulnerable women & girls
Grand Challenges Canada today announced 18 projects extending innovative forms of health-related lifelines to some of humanity's most acutely impoverished, neglected and vulnerable women and girls, supported by the Government of Canada through Global Affairs Canada.
Grand Challenges Canada

Contact: Liam Brown
liam.brown@grandchallenges.ca
416-583-5821 x5564
Grand Challenges Canada

Public Release: 18-Dec-2017
Nature Materials
Using gold nanoparticles to destroy viruses
EPFL researchers have created nanoparticles that attract viruses and, using the pressure resulting from the binding process, destroy them. This revolutionary approach could lead to the development of broad-spectrum antiviral drugs.
Fondation Leenaards, NCCR on 'Bio-Inspired Materials'

Contact: Francesco Stellacci
francesco.stellacci@epfl.ch
41-216-937-872
Ecole Polytechnique Fédérale de Lausanne

Public Release: 14-Dec-2017
Journal of Infectious Diseases
Forty years after first Ebola outbreak, survivors show signs they can stave off new infection
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks. UCLA researchers located the 14 Ebola survivors of the 1976 outbreak who, in January 2016, were still living in the same small, remote villages in the forests of the Équateur Province of northwestern Democratic Republic of the Congo.
Bill and Melinda Gates Foundation, Faucett Catalyst Fund, NIH/National Institute of Allergy and Infectious Diseases, German Research Foundation, NIH/Fogarty International Center, and others

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-267-7120
University of California - Los Angeles Health Sciences

Public Release: 13-Dec-2017
Clinical Therapeutics
Unique sensory responses to the pediatric HIV medication Kaletra
Research from the Monell Center documented wide individual differences to the taste of the life-saving HIV medication Kaletra and identified genetic sources of the taste variation. The findings suggest that the growing field of pharmacogenetics should assess the sensory response to medicines to promote medication compliance and treatment success.
NIH/National Institute on Deafness and Other Communication Disorders

Contact: Leslie Stein
stein@monell.org
267-519-4707
Monell Chemical Senses Center

Public Release: 13-Dec-2017
Current Pharmaceutical Design
2-hydroxypropyl-β-cyclodextrins and blood-brain barrier in Niemann-Pick Disease type C1
The rare, chronic, autosomal-recessive lysosomal storage disease Niemann-Pick disease type C1 (NPC1) is characterized by progressively debilitating and ultimately fatal neurological manifestations. There is an urgent need for disease-modifying therapies that address NPC1 neurological pathophysiology; and passage through the blood-brain barrier represents an important consideration for novel NPC1 drugs.

Contact: Faizan ul Haq
faizan@benthamscience.net
Bentham Science Publishers

Public Release: 13-Dec-2017
New Michelson Prizes for Human Immunology and Vaccine Research launch
The Michelson Medical Research Foundation (MMRF) together with the Human Vaccines Project announced today the establishment of the Michelson Prizes for Human Immunology and Vaccine Research. The $20 million initiative, funded by the MMRF and administered by the Human Vaccines Project, aims to support young investigators applying innovative research concepts and disruptive technologies to significantly advance the development of future vaccines and therapies to defeat major global diseases.
Michelson Medical Research Foundation, Human Vaccines Project

Contact: Kierstin Coatney
kierstin@gga.nyc
Human Vaccines Project

Public Release: 13-Dec-2017
Canadian Medical Association Journal
Does Chagas disease present a health risk to Canadians?
Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas -- the 'Kissing Bug' disease -- is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal. Experts from Winnipeg and Montreal warn natives of Latin America and their offspring are at risk of contracting Chagas disease.

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-971-4747
McGill University Health Centre

Showing releases 26-50 out of 1424.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>